Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Homberg, Judith R ^a   Olivier, Jocelien D A ^a   Blom, Tom ^a   Arentsen, Tim ^a   van Brunschot, Chantal ^a   Schipper, Pieter ^a   Korte Bouws, Gerdien ^d   van Luijtelaar, Gilles ^c   Reneman, Liesbeth ^b  

^a RADBOUD UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN 1A RECEPTOR; ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG BLOOD LEVEL; ELECTROENCEPHALOGRAPHY; FORCED SWIMMING TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; RAT; STARTLE REFLEX; VENTROMEDIAL PREFRONTAL CORTEX; WAKEFULNESS; AGE; ANIMAL; DEPRESSION; DRUG EFFECT; PHYSIOLOGY;

ANIMALIA; RATTUS;

AGE FACTORS; AMYGDALA; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; BODY WEIGHT; DEPRESSION; DEPRESSIVE DISORDER; FLUOXETINE; NEURONAL PLASTICITY; RATS; WAKEFULNESS;

EID: 79551621411     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016646     Document Type: Article

References (69)

1. Zito JM, Safer DJ, DosReis S, Gardner JF, Soeken K, et al. (2002) Rising prevalence of antidepressants among US youths. Pediatrics 109: 721-727.
2. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, et al. (2007) Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 164: 1356-1363.
3. Hammad TA, Laughren T, Racoosin J (2006) Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63: 332-339.
4. March J, Silva S, Petrycki S, Curry J, Wells K, et al. (2004) Fluoxetine, cognitivebehavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292: 807-820.
5. Usala T, Clavenna A, Zuddas A, Bonati M (2008) Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur Neuropsychopharmacol 18: 62-73.
6. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, et al. (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363: 1341-1345.
7. Olfson M, Marcus SC, Shaffer D (2006) Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Arch Gen Psychiatry 63: 865-872.
8. Bhatia SK, Bhatia SC (2007) Childhood and adolescent depression. Am Fam Physician 75: 73-80.
9. Mason SS, Baker KB, Davis KW, Pogorelov VM, Malbari MM, et al. (2009) Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains. Eur J Pharmacol 602: 306-315.
10. Norcross M, Mathur P, Enoch AJ, Karlsson RM, Brigman JL, et al. (2008) Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl) 200: 413-424.
11. Bhansali P, Dunning J, Singer SE, David L, Schmauss C (2007) Early life stress alters adult serotonin 2C receptor pre-mRNA editing and expression of the alpha subunit of the heterotrimeric G-protein G q. J Neurosci 27: 1467-1473.
12. Oh JE, Zupan B, Gross S, Toth M (2009) Paradoxical Anxiogenic Response of Juvenile Mice to Fluoxetine. Neuropsychopharmacology 34: 2197-2207.
13. LaRoche RB, Morgan RE (2007) Adolescent fluoxetine exposure produces enduring, sex-specific alterations of visual discrimination and attention in rats. Neurotoxicol Teratol 29: 96-107.
14. Iniguez SD, Warren BL, Bolanos-Guzman CA (2010) Short- and Long-Term Functional Consequences of Fluoxetine Exposure During Adolescence in Male Rats. Biol Psychiatry 67: 1057-66.
15. Simon GE (2006) The antidepressant quandary-considering suicide risk when treating adolescent depression. N Engl J Med 355: 2722-2723.
16. Dohler KD, Wuttke W (1975) Changes with age in levels of serum gonadotropins, prolactin and gonadal steroids in prepubertal male and female rats. Endocrinology 97: 898-907.
17. Hefner K, Cameron HA, Karlsson RM, Holmes A (2007) Short-term and longterm effects of postnatal exposure to an adult male in C57BL/6J mice. Behav Brain Res 182: 344-348.
18. Spear LP, Brake SC (1983) Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol 16: 83-109.
19. Gaspar P, Cases O, Maroteaux L (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4: 1002-1012.
20. Homberg JR, Schubert D, Gaspar P (2009) New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol Sci 31: 60-5.
21. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455: 894-902.
22. Amat J, Baratta MV, Paul E, Bland ST, Watkins LR, et al. (2005) Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci 8: 365-71.
23. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, et al. (2009) The moodimproving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 14: 764-73.
24. Castro JE, Varea E, Márquez C, Cordero MI, Poirier G, et al. (2010) Role of the amygdala in antidepressant effects on hippocampal cell proliferation and survival and on depression-like behavior in the rat. PLoS One 5: e8618.
25. Varea E, Castillo-Gomez E, Gomez-Climent MA, Blasco-Ibanez JM, Crespo C, et al. (2007a) Chronic antidepressant treatment induces contrasting patterns of synaptophysin and PSA-NCAM expression in different regions of the adult rat telencephalon. Eur Neuropsychopharmacol 17: 546-557.
26. Varea E, Blasco-Ibáñez JM, Gómez-Climent MA, Castillo-Gómez E, Crespo C, et al. (2007b) Chronic fluoxetine treatment increases the expression of PSANCAM in the medial prefrontal cortex. Neuropsychopharmacology 32: 803-12.
27. Blier P (2010) Altered function of the serotonin 1A autoreceptor and the antidepressant response. Neuron 65: 1-2.
28. Hensler JG (2002) Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26: 565-573.
29. Grzegorzewska M, Mackowiak M, Wedzony K, Hess G (2010) 5-HT1A receptors mediate detrimental effects of cocaine on long-term potentiation and expression of polysialylated neural cell adhesion molecule protein in rat dentate gyrus. Neuroscience 166: 122-131.
30. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edition ed. San Diego: Academic Press.
31. Homberg JR, De Boer SF, Raaso HS, Olivier JD, Verheul M, et al. (2008) Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats. Psychopharmacology (Berl) 200: 367-380.
32. Olivier JD, Van Der Hart MG, Van Swelm RP, Dederen PJ, Homberg JR, et al. (2008) A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152: 573-584.
33. van Luijtelaar EL (1997) Spike-wave discharges and sleep spindles in rats. Acta Neurobiol Exp (Wars) 57: 113-121.
34. Duverneuil C, de la Grandmaison GL, de MP, Alvarez JC (2003) A highperformance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs. Ther Drug Monit 25: 565-573.
35. Olivier JD, Jans LA, Korte-Bouws GA, Korte SM, Deen PM, et al. (2008) Acute tryptophan depletion dose dependently impairs object memory in serotonin transporter knockout rats. Psychopharmacology (Berl) 200: 243-254.
36. Fuller RW, Hemrick-Luecke SK, Snoddy HD (1994) Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor. J Neural Transm Gen Sect 96: 165-177.
37. Garattini S, Mennini T, Samanin R (1989) Reduction of food intake by manipulation of central serotonin. Current experimental results. Br J Psychiatry Suppl. 41-51.
38. Murray EA (2007) The amygdala, reward and emotion. Trends Cogn Sci 11: 489-497.
39. Kurt M, Arik AC, Celik S (2000) The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice. J Basic Clin Physiol Pharmacol 11: 173-180.
40. Schulz D, Buddenberg T, Huston JP (2007) Extinction-induced ''despair'' in the water maze, exploratory behavior and fear: effects of chronic antidepressant treatment. Neurobiol Learn Mem 87: 624-634.
41. Popa D, Lena C, Alexandre C, Adrien J (2008) Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28: 3546-3554.
42. Bourdeaux R, Desor D, Lehr PR, Younos C, Capolaghi B (1998) Effects of fluoxetine and norfluoxetine on 5-hydroxytryptamine metabolism in blood platelets and brain after administration to rats. J Pharm Pharmacol 50: 1387-1392.
43. Argyropoulos SV, Wilson SJ (2005) Sleep disturbances in depression and the effects of antidepressants. Int Rev Psychiatry 17: 237-245.
44. Bakalian MJ, Fernstrom JD (1990) Effects of L-tryptophan and other amino acids on electroencephalographic sleep in the rat. Brain Res 528: 300-307.
45. Giedke H, Schwarzler F (2002) Therapeutic use of sleep deprivation in depression. Sleep Med Rev 6: 361-377.
46. Monti JM, Jantos H (2006) Effects of the 5-HT(7) receptor antagonist SB- 269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat. Behav Brain Res 167: 245-250.
47. Thase ME (1998) Depression, sleep, and antidepressants. J Clin Psychiatry 59(Suppl 4): 55-65.
48. Feige B, Voderholzer U, Riemann D, Dittmann R, Hohagen F, et al. (2002) Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects. Neuropsychopharmacology 26: 246-258.
49. Vazquez-Palacios G, Hernandez-Gonzalez M, Guevara Perez MA, Bonilla- Jaime H (2010) Nicotine and fluoxetine induce arousing effects on sleep-wake cycle in antidepressive doses: a possible mechanism of antidepressant-like effects of nicotine. Pharmacol Biochem Behav 94: 503-509.
50. Ivarsson M, Paterson LM, Hutson PH (2005) Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats. Eur J Pharmacol 522: 63-71.
51. Kirov R, Moyanova S (2002) Distinct sleep-wake stages in rats depend differentially on age. Neurosci Lett 322: 134-136.
52. Shanahan NA, Holick Pierz KA, Masten VL, Waeber C, Ansorge M, et al. (2009) Chronic reductions in serotonin transporter function prevent 5-HT1Binduced behavioral effects in mice. Biol Psychiatry 65: 401-408.
53. Dulawa SC, Hen R, Scearce-Levie K, Geyer MA (1997) Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice. Psychopharmacology (Berl) 132: 125-134.
54. Farid M, Martinez ZA, Geyer MA, Swerdlow NR (2000) Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors. Ontogeny and strain differences. Neuropsychopharmacology 23: 623-632.
55. Gogos A, Kusljic S, van den BM (2005) 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Pharmacol Biochem Behav 81: 664-672.
56. Gogos A, Bogeski M, van den BM (2008) Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behav Pharmacol 19: 548-561.
57. Sipes TA, Geyer MA (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33: 441-448.
58. Alvarez JC, Bothua D, Collignon I, Advenier C, Spreux-Varoquaux O (1998) Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 707: 175-180.
59. Amsterdam JD, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, et al. (1997) Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. Am J Psychiatry 154: 963-969.
60. Lundmark J, Reis M, Bengtsson F (2001) Serum concentrations of fluoxetine in the clinical treatment setting. Ther Drug Monit 23: 139-147.
61. Orsulak PJ, Kenney JT, Debus JR, Crowley G, Wittman PD (1988) Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection. Clin Chem 34: 1875-1878.
62. Strauss WL, Unis AS, Cowan C, Dawson G, Dager SR (2002) Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders. Am J Psychiatry 159: 755-760.
63. Kecskemeti V, Rusznak Z, Riba P, Pal B, Wagner R, et al. (2005) Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. Brain Res Bull 67: 126-132.
64. Rutishauser U (1996) Polysialic acid and the regulation of cell interactions. Curr Opin Cell Biol 8: 679-684.
65. Seki T, Rutishauser U (1998) Removal of polysialic acid-neural cell adhesion molecule induces aberrant mossy fiber innervation and ectopic synaptogenesis in the hippocampus. J Neurosci 18: 3757-3766.
66. McEwen BS, Chattarji S (2004) Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur Neuropsychopharmacol 14(Suppl 5): S497-S502.
67. Dityatev A, Dityateva G, Sytnyk V, Delling M, Toni N, et al. (2004) Polysialylated neural cell adhesion molecule promotes remodeling and formation of hippocampal synapses. J Neurosci 24: 9372-82.
68. Varea E, Castillo-Gómez E, Gómez-Climent MA, Guirado R, Blasco- Ibáñez JM, et al. (2009) Differential evolution of PSA-NCAM expression during aging of the rat telencephalon. Neurobiol Aging 30: 808-18.
69. Yew DT, Yeung LY, Wai MS, Mak YT (2009) 5-HT 1A and 2A receptor positive cells in the cerebella of mice and human and their decline during aging. Microsc Res Tech 72: 684-9.